PATENT CLAIM ANALYSIS

Application Number: 16065937
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["549", "404000"]

Abstract:
The present invention provides an α,β-unsaturated amide compound or a pharmaceutically acceptable salt or the like thereof having anticancer activity and the like represented by the following formula (I): [wherein, “A” represents optionally substituted heterocyclic diyl, R 1  represents hydrogen atom or optionally substituted lower alkyl, R 2  represents optionally substituted aryl, optionally substituted cycloalkyl, optionally substituted aliphatic heterocyclic group or optionally substituted aromatic heterocyclic group, X represents —O—, —S—, —SO 2 —, —NR X1 — (wherein, R X1  represents hydrogen atom or lower alkyl), —CHR X2 — (wherein, R X2  represents hydrogen atom or hydroxy), —CH═CH—, —CO— or —NH—CO—, and n1 and n2 are the same or different, and each represents 0 or 1].

Claim (Index 15):
The \u03b1,\u03b2-unsaturated amide compound or a pharmaceutically acceptable salt thereof according to  claim 1 , wherein the heterocyclic diyl m the optionally substituted heterocyclic diyl is 5,6,7,8-tetrahydroisoquinolinediyl.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 94.0
- Lexical Diversity: 1.95946
- Patent Class: 549.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13983248', '13128516', '14418253', '12602312', '13123761']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7957906185328074
- 35 USC 102 Novelty (BERT): 0.5482191412299823
- Combined Prediction Score: 0.7710334708025249
- Mean Citation Score: 394.70623200000006
- Max Citation Score: 412.2953
- Similarity Product: 330.84402939823866

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test